Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:ACKNOWLEDGEMENTS TO REVIEWERS (2016)
Volume: 10 Issue: 2
Author(s): .
Affiliation:
Export Options
About this article
Cite this article as:
. , ACKNOWLEDGEMENTS TO REVIEWERS (2016), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2016; 10 (2) . https://dx.doi.org/10.2174/187221481002170518185930
DOI https://dx.doi.org/10.2174/187221481002170518185930 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Article Metrics
Related Articles
-
Editorial [Hot Topic:Toward Translational Research on VIP AND PACAP (Executive Editor: A. Arimura)]
Current Pharmaceutical Design Dendritic Cells and Immunomodulation: Role in Health and Disease
Current Immunology Reviews (Discontinued) Lipid Modulation of Intravascular and Cellular Sodium Handling:Mechanistic Insights and Potential Clinical Implications
Current Vascular Pharmacology Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
Current Alzheimer Research Regulatable Gene Expression Systems for Gene Therapy
Current Gene Therapy Telomere Length Variations in Aging and Age-Related Diseases
Current Aging Science Hepatic Mediators of Lipid Metabolism and Ketogenesis: Focus on Fatty Liver and Diabetes
Current Diabetes Reviews Arterial Hypertension and Kidney Circulation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Chemometric Study of Retention Indices of Some Thiazolidinediones Derivatives in Two Low Polarity Stationary Phases
Combinatorial Chemistry & High Throughput Screening Intravenous Glycoprotein IIb / IIIa Antagonists: Their Benefits, Problems and Future Developments
Current Pharmaceutical Design Artificial Virus as Trump-card to Resolve Exigencies in Targeted Gene Delivery
Mini-Reviews in Medicinal Chemistry The Arrestin Fold: Variations on a Theme
Current Genomics Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications
Current Diabetes Reviews Molecular Targets and Targeted Therapies for Malignant Mesothelioma
Current Medicinal Chemistry Metabolic Syndrome Racial Differences in Adolescents
Current Diabetes Reviews Involvement of the ADAM 12 in Thrombin-Induced Rat's VSMCs Proliferation
Current Medicinal Chemistry Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients <i>In vivo</i> and <i>In vitro</i>
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Targeting Strategies for Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry The Cardiac Antihypertrophic Effects of Cyclic GMP-Generating Agents: An Experimental Framework for Novel Treatments of Left Ventricular Remodeling
Vascular Disease Prevention (Discontinued) Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
Current Pharmaceutical Design